AstraZeneca: all 4,196 studies
Page 42 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)CompletedNCT00163462Phase 3
- Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)CompletedNCT00163449Phase 3
- Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)CompletedNCT00163436Phase 3
- Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)CompletedNCT00163423Phase 3
- Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)CompletedNCT00163410Phase 3
- Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)CompletedNCT00163397Phase 3
- Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)CompletedNCT00163384Phase 3
- Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)CompletedNCT00163371Phase 3
- Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)CompletedNCT00163358Phase 3
- Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)CompletedNCT00163345Phase 3
- Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)CompletedNCT00163332Phase 3
- Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)CompletedNCT00163319Phase 3
- A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic SubjectsCompletedNCT00162305Phase 2
- Seroquel in Acute Mania: Study to Investigate if Valproate Add-On Therapy is Superior to Quetiapine Monotherapy in Acutely Manic PatientsTerminatedNCT00139074Phase 4
- Long-Term Follow-Up Study of Psoriasis PatientsCompletedNCT00131066
- Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of AgeCompletedNCT00128167Phase 3
- Study Evaluating Gefitinib (IRESSA®) in Subjects With Solid Malignancies That Are Locally Advanced, Recurrent or MetastaticCompletedNCT00127829Phase 1
- BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's LymphomaCompletedNCT00126646Phase 1
- Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy AdultsCompletedNCT00125944Phase 3
- Trial of MEDI-507 in CD2-Positive Lymphoproliferative DiseaseTerminatedNCT00123942Phase 1
- Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) PatientsCompletedNCT00122330Phase 3
- Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With EculizumabCompletedNCT00122304Phase 3
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedNCT00119626Phase 3
- Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar DisorderCompletedNCT00114686Phase 3
- A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCompletedNCT00112021Phase 2
- Study to Evaluate MEDI-534 in Healthy AdultsCompletedNCT00111878
- Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant MelanomaCompletedNCT00111696Phase 1
- Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)CompletedNCT00111579Phase 2
- Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 DiabetesCompletedNCT00111540Phase 3
- The HERO-study: Effects of Roflumilast in Patients With COPD (Chronic Obstructive Pulmonary Disease) (BY217/M2-121)CompletedNCT00108823Phase 3
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCompletedNCT00108004Phase 3
- Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00107731Phase 3
- Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedNCT00107107Phase 3
- Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/LeukemiaTerminatedNCT00105313Phase 1
- Study Examining Exenatide Long-Acting Release in Subjects With Type 2 DiabetesCompletedNCT00103935Phase 2
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
- PROCLAIM: Effect of AC2592 Administered by Continuous Subcutaneous Infusion in Subjects With Advanced Chronic Congestive Heart FailureCompletedNCT00099580Phase 2
- Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic AgentsCompletedNCT00099333Phase 2
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and MetforminCompletedNCT00099320Phase 3
- Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCompletedNCT00093002Phase 2
- Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung CancerWithdrawnNCT00090675Phase 3
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaCompletedNCT00090324Phase 3
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I ManiaCompletedNCT00090311Phase 3
- AZD5438 in Patients With Advanced Solid MalignanciesCompletedNCT00088790Phase 1
- Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)CompletedNCT00088179Phase 3
- CP-675,206 In Patients With Advanced MelanomaCompletedNCT00086489Phase 2
- Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid LeukemiaCompletedNCT00086099Phase 1/2
- Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNCT00085969Phase 2
- Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00085891Phase 3
- Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar DepressionCompletedNCT00083954Phase 3
- Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast CancerCompletedNCT00082277Phase 4
- Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I DisorderCompletedNCT00081380Phase 3
- Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerCompletedNCT00081315Phase 2
- Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison SyndromeCompletedNCT00079833Phase 3
- BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaSuspendedNCT00077493Phase 1
- Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast CancerCompletedNCT00077025Phase 2
- Iressa Versus Docetaxel (Taxotere)CompletedNCT00076388Phase 3
- OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)CompletedNCT00076089Phase 3
- The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)CompletedNCT00076076Phase 3
- Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedNCT00075959Phase 2
- CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate CancerCompletedNCT00075192Phase 1/2
- BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell LeukemiaCompletedNCT00074048Phase 2
- Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)CompletedNCT00073177Phase 3
- MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate CancerCompletedNCT00072930Phase 2
- Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to MethotrexateCompletedNCT00069017Phase 2
- Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic MelanomaCompletedNCT00066196Phase 2
- Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)SuspendedNCT00065572Phase 2
- The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerCompletedNCT00065325Phase 3
- Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.TerminatedNCT00065117Phase 2
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)CompletedNCT00062582Phase 3
- Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedNCT00061022Phase 3
- Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar DepressionCompletedNCT00060489Phase 3
- Arimidex in McCune Albright SyndromeCompletedNCT00055302Phase 2
- Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary BypassCompletedNCT00048308Phase 3
- Evaluation of an Orally Administered Medication When Taken in Conjunction With PramlintideCompletedNCT00044707Phase 2
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00044694Phase 2
- Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea CombinationCompletedNCT00044668Phase 3
- Evaluation of the Effect of Pramlintide on Satiety and Food IntakeCompletedNCT00042601Phase 2
- Evaluation of the Bioavailability of PramlintideCompletedNCT00042471Phase 2
- Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlCompletedNCT00042458Phase 3
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.TerminatedNCT00040157Phase 2
- Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNCT00040144Phase 2
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a SulfonylureaCompletedNCT00039026Phase 3
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With MetforminCompletedNCT00039013Phase 3
- Reversal of Ventricular Remodeling With Toprol-XLCompletedNCT00038077Phase 3
- Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
- Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes MellitusCompletedNCT00035984Phase 3
- A Comparison of Seroquel vs. Risperidone in SchizophreniaCompletedNCT00034905Phase 4
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
- Iressa Expanded Access Program (EAP)CompletedNCT00034879Phase 3
- Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionCompletedNCT00034359Phase 2
- ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00014690Phase 2
- ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00006049Phase 3
- ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung CancerStatus unknownNCT00006048Phase 3